In genetically modified mice, a study reported that through deletion of the enzyme dihydroceramide desaturase 1, by which the backbone of the ceramide receives a conserved double-bond, a decrease in insulin resistance could be investigated [28]. This evidence concerns the gene DEGS1 and Insulin resistance.